M2 TAMs mediate tumor immunosuppression through the secretion of immunosuppressive cytokines such as IL-1β, IL-6, IL-10, and TGF-β and suppress T cell immune responses through the expression of the immunosuppressive ligand PD-L1 (De Palma and Lewis, 2013). Here, IL6 is linked to neoplasm.